Table 2.
Type and distribution of pulmonary opacities in pediatric patients with parenchymal lung disease
Opacity type | Opacity location | ||||||
---|---|---|---|---|---|---|---|
Age (years) | Interstitial | Hazy opacities | Consolidation | Lower lobes | Perihilar | Peripheral | Diffuse |
11 | x | x | x | x | |||
0.25 | x | x | x | x | x | ||
14 | x | x | x | ||||
14 | x | x | x | x | |||
16 | x | x | x | ||||
18 | x | x | |||||
17 | x | x | x | ||||
4 | x | x | x | x | |||
15 | x | x | x | x | |||
14 | x | x | x | ||||
17 | x | x | |||||
7 | x | x | x | x | |||
8 | x | x | x | x | |||
3 | x | x | x | x | |||
4 | x | x | x | x | |||
Totala | 6 | 8 | 13 | 9 | 11 | 1 | 5 |
aThis table includes 15 patients with parenchymal lung disease. The table excludes three patients diagnosed with myocarditis with no parenchymal lung disease and one 3-month-old who presented with fever and respiratory symptoms and had normal chest radiographs